D. Zvosec

发表

Adverse events, including death, associated with the use of 1,4-butanediol.

Stephen W. Smith, B. Hall, D. Zvosec, 2001, The New England journal of medicine.

Gamma-hydroxybutyric acid.

Stephen W. Smith, D. Zvosec, 2005, The New England journal of medicine.

Case series of 226 γ-hydroxybutyrate-associated deaths: lethal toxicity and trauma.

Stephen W. Smith, J. Dyer, D. Zvosec, 2011, The American journal of emergency medicine.

Three deaths associated with use of Xyrem.

Stephen W. Smith, B. Hall, D. Zvosec, 2009, Sleep medicine.

Unsupported "Efficacy" claims of gamma hydroxybutyrate (GHB).

Stephen W. Smith, D. Zvosec, 2003, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

Agitation is common in γ-hydroxybutyrate toxicity

Stephen W. Smith, D. Zvosec, 2005 .

Electrocardiographic Diagnosis of Acute Coronary Occlusion Myocardial Infarction in Ventricular Paced Rhythm Using the Modified Sgarbossa Criteria.

Jennifer L. White, R. Body, A. Chang, 2021, Annals of emergency medicine.

Physostigmine for gamma-hydroxybutyrate coma: Inefficacy, adverse events, and review

Stephen W. Smith, D. Zvosec, R. Westfal, 2007, Clinical toxicology.

Comment on “The Abrupt Cessation of Therapeutically Administered Sodium Oxybate (GHB) May Cause Withdrawal Symptoms”

Stephen W. Smith, D. Zvosec, 2004 .

A Reply to “Comment on ‘The Abrupt Cessation of Therapeutically Administered Sodium Oxybate (GHB) May Cause Withdrawal Symptoms’”

Stephen W. Smith, D. Zvosec, 2004, Journal of Toxicology Clinical Toxicology.

γ-Hydroxybutyrate addiction and withdrawal: From the γ-Hydroxybutyrate addiction study

Stephen W. Smith, D. Zvosec, 2004 .

Commenting on"a review of tolerability and abuse liability of gamma-hydroxybutyric acid for insomnia in patients with schizophrenia," by Kantrowitzet al.

Stephen W. Smith, D. Zvosec, 2010, Clinical therapeutics.

Rigorous study of Xyrem®/sodium oxybate use among patients with obstructive sleep apnea and other conditions of compromised respiratory function is critically needed.

M. Mahowald, Stephen W. Smith, D. Zvosec, 2011, Sleep medicine.

Further research on Xyrem®/sodium oxybate treatment of patients with obstructive sleep apnea is needed

M. Mahowald, Stephen W. Smith, D. Zvosec, 2011, Sleep and Breathing.

Response to “Xyrem® (sodium oxybate) postmarketing adverse event reporting system”

Stephen W. Smith, D. Zvosec, 2010 .

In Response to The Influence of Serial ECG on the Test Characteristics of the Sgarbossa Criteria in Ventricular Paced Rhythms (published in Annals volume 78, issue 6)

Stephen W. Smith, K. Dodd, D. Zvosec, 2022, Annals of Emergency Medicine.